Zymeworks Total Non Current Liabilities 2011-2026 | ZYME

Annual Total Non Current Liabilities Zymeworks

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	2.86 M	40 M	33.9 M	866 K	68.4 M	59 K	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
68.4 M	59 K	24.3 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Aquestive Therapeutics AQST	90.3 M	$ 4.2	2.57 %	$ 364 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
argenx SE ARGX	226 M	$ 832.2	-0.96 %	$ 25 B	Niderland
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Ascendis Pharma A/S ASND	101 M	$ 231.03	-1.69 %	$ 5 B	Danmark
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.35	0.72 %	$ 8.06 B	Australia
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	62.5 K	$ 1.25	0.1 %	$ 1.85 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
BioMarin Pharmaceutical BMRN	635 M	$ 61.64	-1.57 %	$ 11.7 B	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Atea Pharmaceuticals AVIR	69.2 M	$ 4.59	-1.4 %	$ 387 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Capricor Therapeutics CAPR	4.86 M	$ 28.36	1.61 %	$ 759 M	USA
CASI Pharmaceuticals CASI	38.2 M	$ 0.36	-54.61 %	$ 49 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 164.67	-3.11 %	$ 8.19 B	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	981 K	$ 12.11	-4.27 %	$ 797 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	9.03 B	$ 190.86	-2.19 %	$ 28 B	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	65.4 M	-	0.59 %	$ 63 K	USA
Aptose Biosciences APTO	10.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	114 K	-	-39.0 %	$ 4.57 M	USA
Cellectis S.A. CLLS	109 M	$ 4.17	4.77 %	$ 116 M	France
Aridis Pharmaceuticals ARDS	854 K	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	341 M	$ 111.05	0.14 %	$ 27.2 B	Germany